VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $731,539 (100.0% shares, 0.0% debt)

Holdings (26)

Instil Bio Inc 16.1%
Value ($000) $117,461 Shares 6,865,076 Est. Cost $25.08 Unrealized
ACRS Aclaris Therapeutics Inc 9.1%
Value ($000) $66,360 Shares 4,563,962 Est. Cost $13.57 Unrealized +11.6%
TVTX Travere Therapeutics Inc 8.5%
Value ($000) $61,925 Shares 1,994,997 Est. Cost $19.66 Unrealized +43.2%
RLMD Relmada Therapeutics Inc 7.0%
Value ($000) $51,145 Shares 2,270,072 Est. Cost $31.54 Unrealized -29.5%
GHRS GH Research PLC 6.4%
Value ($000) $47,173 Shares 2,021,985 Est. Cost $20.70 Unrealized +6.1%
WHWK Aadi Bioscience Inc 5.0%
Value ($000) $36,935 Shares 1,529,402 Est. Cost $30.48 Unrealized -17.6%
VRDN Viridian Therapeutics Inc 5.0%
Value ($000) $36,632 Shares 1,852,919 Est. Cost $18.59 Unrealized +0.2%
Marinus Pharmaceuticals Inc 4.7%
Value ($000) $34,216 Shares 2,880,096 Est. Cost $12.23 Unrealized
CLDX Celldex Therapeutics Inc 4.6%
Value ($000) $33,428 Shares 865,116 Est. Cost $15.71 Unrealized +177.4%
Tricida Inc 4.6%
Value ($000) $33,411 Shares 3,494,851 Est. Cost $9.01 Unrealized
LIANY LianBio 4.5%
Value ($000) $33,131 Shares 5,378,341 Est. Cost $6.16 Unrealized
VistaGen Therapeutics Inc 4.3%
Value ($000) $31,292 Shares 16,047,286 Est. Cost $2.02 Unrealized
Chinook Therapeutics Inc 2.9%
Value ($000) $20,939 Shares 1,283,821 Est. Cost $16.31 Unrealized
Graphite Bio Inc 2.7%
Value ($000) $20,045 Shares 1,612,617 Est. Cost $30.73 Unrealized
NUVL Nuvalent Inc 2.1%
Value ($000) $15,307 Shares 803,951 Est. Cost $29.01 Unrealized -23.2%
Kinnate Biopharma Inc 1.9%
Value ($000) $13,698 Shares 773,014 Est. Cost $39.78 Unrealized
Athira Pharma Inc 1.8%
Value ($000) $13,030 Shares 1,000,000 Est. Cost $20.05 Unrealized
CNTA Centessa Pharmaceuticals PLC 1.7%
Value ($000) $12,693 Shares 1,127,272 Est. Cost $22.21 Unrealized
ATYR aTyr Pharma Inc 1.6%
Value ($000) $11,691 Shares 1,565,000 Est. Cost $5.98 Unrealized +39.5%
COGT Cogent Biosciences Inc 1.3%
Value ($000) $9,342 Shares 1,088,817 Est. Cost $10.99 Unrealized -20.9%
Affimed NV 1.1%
Value ($000) $7,886 Shares 1,428,571 Est. Cost $5.52 Unrealized
OLMA Olema Pharmaceuticals Inc 1.0%
Value ($000) $7,644 Shares 816,651 Est. Cost $46.89 Unrealized -55.8%
CVRX CVRx Inc 0.9%
Value ($000) $6,523 Shares 533,370 Est. Cost $28.00 Unrealized -48.2%
Akoya Biosciences Inc 0.8%
Value ($000) $6,124 Shares 400,000 Est. Cost $19.34 Unrealized
Astria Therapeutics Inc 0.4%
Value ($000) $2,905 Shares 538,999 Est. Cost $8.84 Unrealized
CRVS Corvus Pharmaceuticals Inc 0.1%
Value ($000) $603 Shares 250,000 Est. Cost $2.96 Unrealized +31.0%